NGeneBio Co., Ltd. (KOSDAQ:354200)
South Korea · Delayed Price · Currency is KRW 700.00
-21.00 (-2.91%)
At close: Oct 23, 2026
NGeneBio Market Cap
NGeneBio has a market cap or net worth of 11.26 billion as of October 23, 2026. It is the 42,326th most valuable company in the world and the 2,606th biggest in South Korea. Its market cap has decreased by 71.79% in one year.
Market Cap
11.26B
Enterprise Value
40.64B
Revenue
41.80B
Global Rank
Country Rank
#2,606 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since December 10, 2020, NGeneBio's market cap has decreased from 313.33B to 11.26B, a decrease of -96.41%. That is a compound annual growth rate of -43.25%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 11.26B | -69.20% |
| Dec 30, 2025 | 36.56B | 12.79% |
| Dec 30, 2024 | 32.41B | -54.77% |
| Dec 28, 2023 | 71.66B | -38.24% |
| Dec 29, 2022 | 116.03B | -42.38% |
| Dec 30, 2021 | 201.38B | -46.99% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Kainos Medicine | 35.56B |
| Eutilex.Co.,Ltd | 35.32B |
| Progen | 32.13B |
| Shaperon | 21.36B |
| Poongjeon Pharmacy CO.,LTD. | 19.45B |
| Plumbline Life Sciences | 18.69B |
| Moogene Medi | 18.49B |
| MOA Life Plus | 10.88B |